Researchers from KU Leuven, the University of California Davis Medical Center, the University of Cologne, and over 20 ...

Fungal infections are getting harder to treat as they grow more resistant to available drugs, according to research published ...

Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...

Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Vietnam Invasive Fungal Infection Market Key Takeaways: The Vietnam Invasive Fungal Infection (IFI) market is experiencing significant growth propelled by factors such as an increasing incidence of ...

Candida auris is a dangerous fungal pathogen that has become a global health concern. It spreads easily in health care settings and can cause life-threatening infections, especially in patients with ...

Discover 5 dangerous drug-resistant fungi posing epidemic threats. Learn how these deadly superbugs are spreading and what ...

"You can't fight what you can't see. We need better diagnostics to stop C. auris from spreading." Fungal pathogens are a major threat to public health as they are becoming more prevalent and resistant ...

Regarding the pediatric population, mold-active antifungal prophylaxis is recommended for pediatric patients at high risk of IFD, including a subgroup of children with ALL.